NONOF - Eli Lilly rebounds amid bullish views from analysts
2023-10-06 13:09:10 ET
More on Eli Lilly
- Eli Lilly: Big Cancer Bet With Point Biopharma Global Purchase
- Eli Lilly POINTs Toward Radiopharmaceutical Ambitions
- Eli Lilly: Don't Be Fooled By Greed
- Walmart says Ozempic, weight loss drugs impacting sales - Bloomberg
- Eli Lilly announces leadership changes in diabetes and obesity unit
For further details see:
Eli Lilly rebounds amid bullish views from analysts